Double Chin

A double chin is a local accumulation of fat in the chin area, this is due to the laxity of the muscles in the lower two thirds of the face. It occurs in both overweight and normal weight people. The appearance of a double chin can be hereditary. When the elasticity of the skin in the neck area decreases, the subcutaneous fat layer increases there. This makes the double chin more visible. To remove it, it is necessary to tighten the skin of the lower third of the face and remove local fat deposits.

Treatment methods recommended to deal with this problem:


How it works:

A focused ultrasound beam heats the connective tissue under the skin, which causes this layer to contract. This layer is connected with the skin and muscles, therefore, as in plastic surgery, not only the skin, but also the muscle layer is tightened.

HIFU 5D V MAX LOW PAIN uses the same energy power as the legendary ULTERNA, but delivers this energy in frequent, short pulses, thus avoiding severe pain.

Skin tightening, which leads to smoothing of the nasolabial folds, is visible immediately after the procedure, but the effect intensifies over several weeks. A second treatment after 2 weeks is recommended. If necessary, the procedure can be done every 3 months or once a year, depending on the condition of the skin.

Recommended for:
People over 25 and under 65.

Not recommended for: 
Women under 25, as the result will not be noticeable.

People with infections and broken skin, cystic acne, and metal implants in the area to be treated.

Learn more


How it works::

After COG THREADS made of natural bioresorbable material with “hooks” are inserted, the skin is tightened immediately due to the fact that the “hooks” grab onto the tissues and mechanically “lift” them. Then a dense framework of collagen is formed around them, which “supports” the skin.

COG THREADS are resorbed within 3-4 months.

Smoothening of forehead wrinkles often noticeable after the procedure, the final effect is achieved after a month.

Recommended for:
People over 25 years.

Not recommended for::
Patients with acute infectious diseases, blood clotting disorders, immunocompromising diseases and autoimmune diseases

Learn more